Assessment of Functional and Nutritional Status and Skeletal Muscle Mass for the Prognosis of Critically Ill Solid Cancer Patients

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2022 Dec 11

PMID 36497352

Authors

Clara Vigneron

Othmane Laousy

Guillaume Chassagnon

Maria Vakalopoulou

Julien Charpentier

Jerome Alexandre

Matthieu Jamme

Frederic Pene

Affiliations

Soon will be listed here.

Abstract

Simple and accessible prognostic factors are paramount for solid cancer patients experiencing life-threatening complications. The aim of this study is to appraise the impact of functional and nutritional status and skeletal muscle mass in this population. We conducted a retrospective (2007−2020) single-center study by enrolling adult patients with solid cancers requiring unplanned ICU admission. Performance status, body weight, and albumin level were collected at ICU admission and over six months. Skeletal muscle mass was assessed at ICU admission by measuring muscle areas normalized by height (SMI). Four-hundred and sixty-two patients were analyzed, mainly with gastro-intestinal (34.8%) and lung (29.9%) neoplasms. Moreover, 92.8% of men and 67.3% of women were deemed cachectic. In the multivariate analysis, performance status at ICU admission (CSH 1.74 [1.27−2.39], p < 0.001) and the six month increase in albumin level (CSH 0.38 [0.16−0.87], p = 0.02) were independent predictors of ICU mortality. In the subgroup of mechanically ventilated patients, the psoas SMI was independently associated with ICU mortality (CSH 0.82 [0.67−0.98], p = 0.04). Among the 368 ICU-survivors, the performance status at ICU admission (CSH 1.34 [1.14−1.59], p < 0.001) and the six-month weight loss (CSH 1.33 [1.17−2.99], p = 0.01) were associated with a one-year mortality rate. Most cancer patients displayed cachexia at ICU admission. Time courses of nutritional parameters may aid the prediction of short- and long-term outcomes.

Citing Articles

Relevance of Dietary Supplement Use in Gastrointestinal-Cancer-Associated Cachexia.

Yoon S, Grundmann O Nutrients. 2023; 15(15).

PMID: 37571328 PMC: 10421404. DOI: 10.3390/nu15153391.

Pectoralis muscle index might be a factor associated with frailty in older women with breast cancer.

Kizilarslanoglu M, Eryilmaz M, Yortanli B, Unal I, Unal B, Baran N Turk J Med Sci. 2023; 53(3):824-834.

PMID: 37476895 PMC: 10388027. DOI: 10.55730/1300-0144.5645.

References

Park C, Koh Y, Jeon K, Na S, Lim C, Choi W . Impact of Eastern Cooperative Oncology Group Performance Status on hospital mortality in critically ill patients. J Crit Care. 2014; 29(3):409-13. DOI: 10.1016/j.jcrc.2014.01.016. View

Zampieri F, Romano T, Salluh J, Taniguchi L, Mendes P, Nassar Jr A . Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study. Intensive Care Med. 2020; 47(2):170-179. DOI: 10.1007/s00134-020-06184-2. View

Raynard B, Pigneur F, Palma M, Deluche E, Goldwasser F . The prevalence of CT-defined low skeletal muscle mass in patients with metastatic cancer: a cross-sectional multicenter French study (the SCAN study). Support Care Cancer. 2021; 30(4):3119-3129. PMC: 8857123. DOI: 10.1007/s00520-021-06603-0. View

Elfassy M, Ferreyro B, Rozenberg D, Sklar M, Mathur S, Detsky M . Association of Thoracic Computed Tomographic Measurements and Outcomes in Patients with Hematologic Malignancies Requiring Mechanical Ventilation. Ann Am Thorac Soc. 2021; 18(7):1219-1226. DOI: 10.1513/AnnalsATS.202008-914OC. View

Larsson L, Degens H, Li M, Salviati L, Lee Y, Thompson W . Sarcopenia: Aging-Related Loss of Muscle Mass and Function. Physiol Rev. 2018; 99(1):427-511. PMC: 6442923. DOI: 10.1152/physrev.00061.2017. View

Shachar S, Deal A, Weinberg M, Nyrop K, Williams G, Nishijima T . Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy. Clin Cancer Res. 2016; 23(3):658-665. PMC: 5290138. DOI: 10.1158/1078-0432.CCR-16-0940. View

Vigneron C, Charpentier J, Wislez M, Mira J, Lefebvre A, Fournel L . Short-term and Long-term Outcomes of Patients With Lung Cancer and Life-Threatening Complications. Chest. 2021; 160(4):1560-1564. DOI: 10.1016/j.chest.2021.04.056. View

Jaitovich A, Dumas C, Itty R, Chieng H, Khan M, Naqvi A . ICU admission body composition: skeletal muscle, bone, and fat effects on mortality and disability at hospital discharge-a prospective, cohort study. Crit Care. 2020; 24(1):566. PMC: 7507825. DOI: 10.1186/s13054-020-03276-9. View

Jaitovich A, Khan M, Itty R, Chieng H, Dumas C, Nadendla P . ICU Admission Muscle and Fat Mass, Survival, and Disability at Discharge: A Prospective Cohort Study. Chest. 2018; 155(2):322-330. PMC: 6363817. DOI: 10.1016/j.chest.2018.10.023. View

10.

Lach K, Peterson S . Nutrition Support for Critically Ill Patients With Cancer. Nutr Clin Pract. 2017; 32(5):578-586. DOI: 10.1177/0884533617712488. View

11.

Vincent J, Moreno R, Takala J, Willatts S, de Mendonca A, Bruining H . The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996; 22(7):707-10. DOI: 10.1007/BF01709751. View

12.

Kou H, Yeh C, Tsai H, Hsu C, Hsieh Y, Chen W . Sarcopenia is an effective predictor of difficult-to-wean and mortality among critically ill surgical patients. PLoS One. 2019; 14(8):e0220699. PMC: 6687130. DOI: 10.1371/journal.pone.0220699. View

13.

Vigneron C, Charpentier J, Valade S, Alexandre J, Chelabi S, Palmieri L . Patterns of ICU admissions and outcomes in patients with solid malignancies over the revolution of cancer treatment. Ann Intensive Care. 2021; 11(1):182. PMC: 8709803. DOI: 10.1186/s13613-021-00968-5. View

14.

Weijs P, Looijaard W, Dekker I, Stapel S, Girbes A, Oudemans-van Straaten H . Low skeletal muscle area is a risk factor for mortality in mechanically ventilated critically ill patients. Crit Care. 2014; 18(2):R12. PMC: 4028783. DOI: 10.1186/cc13189. View

15.

Martini K, Chassagnon G, Fournel L, Prieto M, Hoang-Thi T, Halm N . Sarcopenia as independent risk factor of postpneumonectomy respiratory failure, ARDS and mortality. Lung Cancer. 2020; 149:130-136. DOI: 10.1016/j.lungcan.2020.09.009. View

16.

Covinsky K, H Covinsky M, Palmer R, Sehgal A . Serum albumin concentration and clinical assessments of nutritional status in hospitalized older people: different sides of different coins?. J Am Geriatr Soc. 2002; 50(4):631-7. DOI: 10.1046/j.1532-5415.2002.50156.x. View

17.

Fearon K, Strasser F, Anker S, Bosaeus I, Bruera E, Fainsinger R . Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011; 12(5):489-95. DOI: 10.1016/S1470-2045(10)70218-7. View

18.

Jullien M, Tessoulin B, Ghesquieres H, Oberic L, Morschhauser F, Tilly H . Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years. Cancers (Basel). 2021; 13(18). PMC: 8466314. DOI: 10.3390/cancers13184503. View

19.

Zampieri F, Iwashyna T, Viglianti E, Taniguchi L, Viana W, Costa R . Association of frailty with short-term outcomes, organ support and resource use in critically ill patients. Intensive Care Med. 2018; 44(9):1512-1520. DOI: 10.1007/s00134-018-5342-2. View

20.

Cox M, Booth M, Ghita G, Wang Z, Gardner A, Hawkins R . The impact of sarcopenia and acute muscle mass loss on long-term outcomes in critically ill patients with intra-abdominal sepsis. J Cachexia Sarcopenia Muscle. 2021; 12(5):1203-1213. PMC: 8517344. DOI: 10.1002/jcsm.12752. View